1-20 of 24
Jeffrey A. Johnson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Type 2 Diabetes and Comorbid Symptoms of Depression and Anxiety: Longitudinal Associations With Mortality Risk

Kiyuri Naicker, Jeffrey A. Johnson, Jens C. Skogen, Douglas Manuel, Simon Øverland, Børge Sivertsen, Ian Colman
Journal: Diabetes Care
Diabetes Care 2017;40(3):352–358
https://doi.org/10.2337/dc16-2018
Published: 11 January 2017
View article titled, Type 2 Diabetes and Comorbid Symptoms of Depression and Anxiety: Longitudinal Associations With Mortality Risk
Open the PDF for Type 2 Diabetes and Comorbid Symptoms of Depression and Anxiety: Longitudinal Associations With Mortality Risk in another window
Includes: Supplementary data
Journal Articles

Prevalence and Timing of Screening and Diagnostic Testing for Gestational Diabetes Mellitus: A Population-Based Study in Alberta, Canada

Lois E. Donovan, Anamaria Savu, Alun L. Edwards, Jeffrey A. Johnson, Padma Kaul
Journal: Diabetes Care
Diabetes Care 2016;39(1):55–60
https://doi.org/10.2337/dc15-1421
Published: 20 October 2015
View article titled, Prevalence and Timing of Screening and Diagnostic Testing for Gestational Diabetes Mellitus: A Population-Based Study in Alberta, Canada
Open the PDF for Prevalence and Timing of Screening and Diagnostic Testing for Gestational Diabetes Mellitus: A Population-Based Study in Alberta, Canada in another window
Includes: Supplementary data
Journal Articles

Collaborative Care Versus Screening and Follow-up for Patients With Diabetes and Depressive Symptoms: Results of a Primary Care–Based Comparative Effectiveness Trial

Jeffrey A. Johnson, Fatima Al Sayah, Lisa Wozniak, Sandra Rees, Allison Soprovich, Weiyu Qiu, Constance L. Chik, Pierre Chue, Peter Florence, Jennifer Jacquier, Pauline Lysak, Andrea Opgenorth, Wayne Katon, Sumit R. Majumdar
Journal: Diabetes Care
Diabetes Care 2014;37(12):3220–3226
https://doi.org/10.2337/dc14-1308
Published: 08 November 2014
View article titled, Collaborative Care Versus Screening and Follow-up for Patients With Diabetes and Depressive Symptoms: Results of a Primary Care–Based Comparative Effectiveness Trial
Open the PDF for Collaborative Care Versus Screening and Follow-up for Patients With Diabetes and Depressive Symptoms: Results of a Primary Care–Based Comparative Effectiveness Trial in another window
Includes: Supplementary data
Journal Articles

Comment on Bordeleau et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366

Marjolein M.J. Zanders, Andrew G. Renehan, Samantha L. Bowker, Bendix Carstensen, Lonneke V. van de Poll-Franse, Jeffrey A. Johnson
Journal: Diabetes Care
Diabetes Care 2014;37(10):e221–e222
https://doi.org/10.2337/dc14-1380
Published: 10 September 2014
View article titled, Comment on Bordeleau et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366
Open the PDF for Comment on Bordeleau et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366 in another window
Journal Articles

Detection Bias and Overestimation of Bladder Cancer Risk in Type 2 Diabetes: A matched cohort study

Isabelle N. Colmers, MSC, Sumit R. Majumdar, MD, Yutaka Yasui, PHD, Samantha L. Bowker, PHD, Carlo A. Marra, PHD, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(10):3070–3075
https://doi.org/10.2337/dc13-0045
Published: 14 September 2013
View article titled, Detection Bias and Overestimation of Bladder Cancer Risk in Type 2 Diabetes: <subtitle>A matched cohort study</subtitle>
Open the PDF for Detection Bias and Overestimation of Bladder Cancer Risk in Type 2 Diabetes: <subtitle>A matched cohort study</subtitle> in another window
Journal Articles

Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival

Craig J. Currie, PHD, Chris D. Poole, PHD, Sara Jenkins-Jones, MSC, Edwin A.M. Gale, MD, Jeffrey A. Johnson, PHD, Christopher Ll. Morgan, MSC
Journal: Diabetes Care
Diabetes Care 2012;35(2):299–304
https://doi.org/10.2337/dc11-1313
Published: 16 January 2012
View article titled, Mortality After Incident Cancer in People With and Without Type 2 Diabetes: <subtitle>Impact of metformin on survival</subtitle>
Open the PDF for Mortality After Incident Cancer in People With and Without Type 2 Diabetes: <subtitle>Impact of metformin on survival</subtitle> in another window
Includes: Supplementary data
Journal Articles

Risk of Breast Cancer After Onset of Type 2 Diabetes: Evidence of detection bias in postmenopausal women

Samantha L. Bowker, PHD, Kathryn Richardson, MSC, Carlo A. Marra, PHD, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2011;34(12):2542–2544
https://doi.org/10.2337/dc11-1199
Published: 14 November 2011
View article titled, Risk of Breast Cancer After Onset of Type 2 Diabetes: <subtitle>Evidence of detection bias in postmenopausal women</subtitle>
Open the PDF for Risk of Breast Cancer After Onset of Type 2 Diabetes: <subtitle>Evidence of detection bias in postmenopausal women</subtitle> in another window
Journal Articles

Effect of Adding Pharmacists to Primary Care Teams on Blood Pressure Control in Patients With Type 2 Diabetes: A randomized controlled trial

Scot H. Simpson, BSP, PHARMD, MSC, Sumit R. Majumdar, MD, MPH, Ross T. Tsuyuki, BSC(PHARM), PHARMD, MSC, Richard Z. Lewanczuk, MD, PHD, Richard Spooner, MD, Jeffrey A. Johnson, BSP, PHD
Journal: Diabetes Care
Diabetes Care 2011;34(1):20–26
https://doi.org/10.2337/dc10-1294
Published: 07 October 2010
View article titled, Effect of Adding Pharmacists to Primary Care Teams on Blood Pressure Control in Patients With Type 2 Diabetes: <subtitle>A randomized controlled trial</subtitle>
Open the PDF for Effect of Adding Pharmacists to Primary Care Teams on Blood Pressure Control in Patients With Type 2 Diabetes: <subtitle>A randomized controlled trial</subtitle> in another window
Includes: Supplementary data
Journal Articles

The Darkening Cloud of Diabetes: Do trends in cardiovascular risk management provide a silver lining?

Dean T. Eurich, PHD, John-Michael Gamble, MSC, Scot H. Simpson, MSC, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(11):2136–2142
https://doi.org/10.2337/dc08-1248
Published: 01 November 2008
View article titled, The Darkening Cloud of Diabetes: <subtitle>Do trends in cardiovascular risk management provide a silver lining?</subtitle>
Open the PDF for The Darkening Cloud of Diabetes: <subtitle>Do trends in cardiovascular risk management provide a silver lining?</subtitle> in another window
Journal Articles

Prospective Study of Hyperglycemia and Cancer Risk: Response to Stattin et al.

Samantha L. Bowker, MSC, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(7):e77
https://doi.org/10.2337/dc07-0544
Published: 01 July 2007
View article titled, Prospective Study of Hyperglycemia and Cancer Risk: <subtitle>Response to Stattin et al.</subtitle>
Open the PDF for Prospective Study of Hyperglycemia and Cancer Risk: <subtitle>Response to Stattin et al.</subtitle> in another window
Journal Articles

Health Care Use and Costs in the Decade After Identification of Type 1 and Type 2 Diabetes: A population-based study

Jeffrey A. Johnson, PHD, Sheri L. Pohar, PHD, Sumit R. Majumdar, MD, MPH
Journal: Diabetes Care
Diabetes Care 2006;29(11):2403–2408
https://doi.org/10.2337/dc06-0735
Published: 01 November 2006
View article titled, Health Care Use and Costs in the Decade After Identification of Type 1 and Type 2 Diabetes: <subtitle>A population-based study</subtitle>
Open the PDF for Health Care Use and Costs in the Decade After Identification of Type 1 and Type 2 Diabetes: <subtitle>A population-based study</subtitle> in another window
Journal Articles

The Natural History of LDL Control in Type 2 Diabetes : A prospective study of adherence to lipid guidelines

Diana Rucker, MD, MSC, Jeffrey A. Johnson, PHD, T.K. Lee, MD, Dean T. Eurich, MSC, Richard Z. Lewanczuk, MD, PHD, Scot H. Simpson, PHARMD, MSC, Ellen L. Toth, MD, Sumit R. Majumdar, MD, MPH
Journal: Diabetes Care
Diabetes Care 2006;29(11):2506–2508
https://doi.org/10.2337/dc06-1205
Published: 01 November 2006
View article titled, The Natural History of LDL Control in Type 2 Diabetes : <subtitle>A prospective study of adherence to lipid guidelines</subtitle>
Open the PDF for The Natural History of LDL Control in Type 2 Diabetes : <subtitle>A prospective study of adherence to lipid guidelines</subtitle> in another window
Journal Articles

Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin: Response to Farooki and Schneider

Samantha L. Bowker, MSC, Sumit R. Majumdar, MD, MPH, Paul Veugelers, PHD, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(8):1990–1991
https://doi.org/10.2337/dc06-0997
Published: 01 August 2006
View article titled, Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin: <subtitle>Response to Farooki and Schneider</subtitle>
Open the PDF for Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin: <subtitle>Response to Farooki and Schneider</subtitle> in another window
Journal Articles

Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin

Samantha L. Bowker, MSC, Sumit R. Majumdar, MD, MPH, Paul Veugelers, PHD, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(2):254–258
https://doi.org/10.2337/diacare.29.02.06.dc05-1558
Published: 01 February 2006
View article titled, Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin
Open the PDF for Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin in another window
Journal Articles

The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes: Response to Bell

Charlotte G. McDonald, MD, MSC, FRCPC, Sumit R. Majumdar, MD, MPH, FRCPC, Jeffrey L. Mahon, MD, MSC, FRCPC, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(2):483–484
https://doi.org/10.2337/diacare.29.02.06.dc05-2045
Published: 01 February 2006
View article titled, The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes: <subtitle>Response to Bell</subtitle>
Open the PDF for The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes: <subtitle>Response to Bell</subtitle> in another window
Journal Articles

Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure

Dean T. Eurich, BSP, MSC, Sumit R. Majumdar, MD, MPH, Finlay A. McAlister, MD, MSC, Ross T. Tsuyuki, BSC(PHARM), PHARMD, MSC, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(10):2345–2351
https://doi.org/10.2337/diacare.28.10.2345
Published: 01 October 2005
View article titled, Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure
Open the PDF for Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure in another window
Journal Articles

The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes

Charlotte G. McDonald, MD, MSC, FRCPC, Sumit R. Majumdar, MD, MPH, FRCPC, Jeffrey L. Mahon, MD, MSC, FRCPC, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(9):2113–2117
https://doi.org/10.2337/diacare.28.9.2113
Published: 01 September 2005
View article titled, The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes
Open the PDF for The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

History of Depression Increases Risk of Type 2 Diabetes in Younger Adults

Lauren C. Brown, BSCPHARM, Sumit R. Majumdar, MD, MPH, FRCPC, Stephen C. Newman, MD, MA, MSC, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(5):1063–1067
https://doi.org/10.2337/diacare.28.5.1063
Published: 01 May 2005
View article titled, History of Depression Increases Risk of Type 2 Diabetes in Younger Adults
Open the PDF for History of Depression Increases Risk of Type 2 Diabetes in Younger Adults in another window
Journal Articles

Generalizability and Persistence of a Multifaceted Intervention for Improving Quality of Care for Rural Patients With Type 2 Diabetes

Jeffrey A. Johnson, PHD, Dean T. Eurich, BSP, MSC, Ellen L. Toth, MD, FRCPC, Richard Z. Lewanczuk, MD, PHD, FRCPC, TK Lee, MD, FRCPC, Sumit R. Majumdar, MD, MPH, FRCPC
Journal: Diabetes Care
Diabetes Care 2005;28(4):783–788
https://doi.org/10.2337/diacare.28.4.783
Published: 01 April 2005
View article titled, Generalizability and Persistence of a Multifaceted Intervention for Improving Quality of Care for Rural Patients With Type 2 Diabetes
Open the PDF for Generalizability and Persistence of a Multifaceted Intervention for Improving Quality of Care for Rural Patients With Type 2 Diabetes in another window
Journal Articles

Reduced Mortality Associated With the Use of ACE Inhibitors in Patients With Type 2 Diabetes

Dean T. Eurich, BSP, MSC, Sumit R. Majumdar, MD, MPH, FRCPC, Ross T. Tsuyuki, PHARMD, MSC, Jeffrey A. Johnson, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(6):1330–1334
https://doi.org/10.2337/diacare.27.6.1330
Published: 01 June 2004
View article titled, Reduced Mortality Associated With the Use of ACE Inhibitors in Patients With Type 2 Diabetes
Open the PDF for Reduced Mortality Associated With the Use of ACE Inhibitors in Patients With Type 2 Diabetes in another window
Includes: Supplementary data